Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy.

Current clinical pharmacology

Volumn 1, Issue 3, 2006, Pages 217-222

  Olivo, Malini ^a   Du, Hong Yan ^a   Bay, Boon Huat ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DRUG DERIVATIVE; HYPERICIN; INTERSTITIAL COLLAGENASE; PERYLENE; REACTIVE OXYGEN METABOLITE;

ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENETICS; HUMAN; LIPID PEROXIDATION; METABOLISM; METHODOLOGY; NASOPHARYNX TUMOR; PHOTOCHEMOTHERAPY; REVIEW;

ANIMALS; CYTOKINES; HUMANS; LIPID PEROXIDATION; MATRIX METALLOPROTEINASE 1; NASOPHARYNGEAL NEOPLASMS; PERYLENE; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES;

EID: 34247122660     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488406778249370     Document Type: Review

References (77)